Position
Fidelity in Ionis Pharmaceuticals Inc
Back to the book · All holders of IONS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $103.9M$58.79 → $62.08
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 35.8M | $1.92B | — | — | — | 0.1% |
| Q1 2026 | 31.5M | $1.85B | $58.79 | $161M | −$228.4M | 0.1% |
| Q2 2026 | 31.6M | $1.96B | $62.08 | $103.9M | $5.61M | 0.1% |